Clearside Biomedical's common stock is $78K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Clearside Biomedical (CLSD) currently reports a common stock of $78K as of September 2025. That compares with $75K in the prior-year period — up 4.0% year over year. Use the charts on this page to explore Clearside Biomedical's common stock history and peer comparisons.
Clearside Biomedical's common stock increased from $75K to $78K — a 4.0% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Clearside Biomedical reported $78K in common stock as of September 2025. That compares with $75K in the prior-year period — up 4.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $78K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clearside Biomedical, and consider following CLSD for alerts when major investors trade the stock.
Clearside Biomedical is classified in the Healthcare sector. On common stock, it currently shows $78K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLSD with unrelated industries.